Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2025-12-29 @ 8:54 AM
Study NCT ID:
NCT04481750
Status:
COMPLETED
Last Update Posted:
2024-08-02
First Post:
2020-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Oral Edaravone in Healthy Adult Males
Sponsor:
Tanabe Pharma Corporation
Organization:
Study Overview
Official Title:
Phase I Study of Oral Edaravone in Healthy Adult Males (Single- and Multiple-dose Study)
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the pharmacokinetics safety, and tolerability of single and multiple doses of edaravone solution and suspension in healthy adult males
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: